Stocks Health care TCRG
OTC · Health careCannaisseur Group Inc. (TCRG)
Cannaisseur Group Inc. brought in $0 of revenue over the twelve months to June 30, 2026, down 100.0% from a year earlier. It posted a net loss of $1M. At June 30, 2026 it held $41 in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.
Key facts about Cannaisseur Group Inc.
- Net worth
- Cannaisseur Group Inc. has a market value (market cap) of $3.6M at the latest share price, and shareholders' equity of -$362.7K on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $0 (-100.0% year on year), with a net loss of $1.8M. Over the 12 months to June 30, 2026: revenue $0, net loss $1M.
- Cash flow
- In fiscal 2025 operations used $127.5K of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 12, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
What Cannaisseur Group Inc. does
Cannaisseur Group Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker TCRG.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $0 | -$1.8M | -$0.03 | n/a |
| 2024 | $700 | -$1.3M | -$0.03 | n/a |
| 2023 | $53.1K | -$128K | $0.00 | n/a |
| 2023 | $88.1K | -$80.1K | $0.00 | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Cannaisseur Group Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 12, 2026
- May 11, 2026
- March 23, 2026
- November 18, 2025
- November 13, 2025Late quarterly report notice NT 10-Q
- September 9, 2025
- August 28, 2025
- August 15, 2025Late quarterly report notice NT 10-Q
- July 21, 2025
- May 16, 2025Late quarterly report notice NT 10-Q
Insider trades
What the people running Cannaisseur Group Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Questions about TCRG
What does Cannaisseur Group Inc. do?
Cannaisseur Group Inc. is a company in the Health care sector, listed on OTC as TCRG. Its shares trade on OTC under the ticker TCRG.
What is Cannaisseur Group Inc.'s net worth?
Cannaisseur Group Inc. has a market value (market cap) of $3.6M at the latest share price, and shareholders' equity of -$362.7K on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Cannaisseur Group Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $1M.
How much revenue does Cannaisseur Group Inc. make?
Over the twelve months to June 30, 2026 Cannaisseur Group Inc. reported revenue of $0. That is 100.0% less than a year earlier.
When did Cannaisseur Group Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026.
Similar companies
Compare TCRG with
Follow TCRG
Get an email when Cannaisseur Group Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Cannaisseur Group Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.